<DOC>
	<DOC>NCT00192114</DOC>
	<brief_summary>Enzastaurin given daily to patients with colorectal cancer who have Stage 4 disease and have not received prior chemotherapy for advanced colorectal cancer</brief_summary>
	<brief_title>Enzastaurin for Patients With Metastatic Colorectal Cancer</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Colonic Neoplasms</mesh_term>
	<criteria>diagnosed with colorectal cancer that is advanced or metastatic (has spread to other parts of the body); able to visit the doctor's office every 28 days for at least 6 months; able to swallow tablets women cannot be pregnant or breastfeeding; no history of significant heart disease or any other significant medical problems as determined by the patient's physician</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2009</verification_date>
</DOC>